Education
About Us
Working with TipRanks
Follow Us
Pharmaron Beijing Co., Ltd. Class H (HK:3759)
:3759
RESEARCH TOOLSreports
Total Valuation
Pharmaron Beijing Co., Ltd. Class H has a market cap or net worth of €65.34B. The enterprise value is HK$33.45B.
Market Cap€65.34B
Enterprise ValueHK$33.45B
Share Statistics
Pharmaron Beijing Co., Ltd. Class H has 301,537,140 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding301,537,140
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Pharmaron Beijing Co., Ltd. Class H’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 8.43%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)8.43%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee574.44K
Profits Per Employee80.21K
Employee Count21,370
Asset Turnover0.51
Inventory Turnover7.23
Valuation Ratios
The current PE Ratio of Pharmaron Beijing Co., Ltd. Class H is 33.6. Pharmaron Beijing Co., Ltd. Class H’s PEG ratio is 13.20.
PE Ratio33.6
PS Ratio1.93
PB Ratio1.74
Price to Fair Value1.74
Price to FCF44.16
Price to Operating Cash Flow20.96
PEG Ratio13.20
Income Statement
In the last 12 months, Pharmaron Beijing Co., Ltd. Class H had revenue of 12.28B and earned 1.79B in profits. Earnings per share was 1.01.
Revenue12.28B
Gross Profit4.20B
Operating Income2.10B
Pretax Income2.09B
Net Income1.79B
EBITDA3.38B
Earnings Per Share (EPS)1.01
Cash Flow
In the last 12 months, operating cash flow was 2.21B and capital expenditures -1.15B, giving a free cash flow of 518.73M billion.
Operating Cash Flow2.21B
Free Cash Flow518.73M
Free Cash Flow per Share1.72
Dividends & Yields
Pharmaron Beijing Co., Ltd. Class H pays an annual dividend of HK$0.219, resulting in a dividend yield of 0.85%
Dividend Per ShareHK$0.219
Dividend Yield0.85%
Payout Ratio26.11%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.01
52-Week Price Change194.05%
50-Day Moving Average21.81
200-Day Moving Average16.41
Relative Strength Index (RSI)70.48
Average Volume (3m)15.64M
Important Dates
Pharmaron Beijing Co., Ltd. Class H upcoming earnings date is Oct 23, 2025, TBA (Not Confirmed).
Last Earnings DateAug 21, 2025
Next Earnings DateOct 23, 2025
Ex-Dividend DateJul 04, 2025
Financial Position
Pharmaron Beijing Co., Ltd. Class H as a current ratio of 1.80, with Debt / Equity ratio of 39.34%
Current Ratio1.80
Quick Ratio1.54
Debt to Market Cap0.22
Net Debt to EBITDA1.14
Interest Coverage Ratio8.63
Taxes
In the past 12 months, Pharmaron Beijing Co., Ltd. Class H has paid 377.10M in taxes.
Income Tax377.10M
Effective Tax Rate0.18
Enterprise Valuation
Pharmaron Beijing Co., Ltd. Class H EV to EBITDA ratio is 8.13, with an EV/FCF ratio of 51.35.
EV to Sales2.24
EV to EBITDA8.13
EV to Free Cash Flow51.35
EV to Operating Cash Flow10.68
Balance Sheet
Pharmaron Beijing Co., Ltd. Class H has €2.16B in cash and marketable securities with €5.61B in debt, giving a net cash position of -€3.45B billion.
Cash & Marketable Securities€2.16B
Total Debt€5.61B
Net Cash-€3.45B
Net Cash Per Share-€11.45
Tangible Book Value Per Share€5.97
Margins
Gross margin is 34.47%, with operating margin of 17.14%, and net profit margin of 14.61%.
Gross Margin34.47%
Operating Margin17.14%
Pretax Margin17.04%
Net Profit Margin14.61%
EBITDA Margin27.56%
EBIT Margin19.02%
Analyst Forecast
The average price target for Pharmaron Beijing Co., Ltd. Class H is €33.26, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target€33.26
Price Target Upside19.81% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast13.51%
EPS Growth Forecast-28.45%